{"filing":{"accession_number":"0001213900-26-069086","cik":"0001967621","ticker":"ATGL","company_name":"Alpha Technology Group Ltd","form":"6-K","filing_date":"2026-06-16","report_date":null,"primary_document":"ea0294783-6k_alpha.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1967621/000121390026069086/ea0294783-6k_alpha.htm"},"events":[{"id":12340,"run_id":10908,"accession_number":"0001213900-26-069086","anchor_item_number":"EX-99.1","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"This exhibit announces a strategic partnership between Alpha Technology Group and Wai Yuen Tong Medicine Co. Ltd. to deploy a blockchain-based traceability system for traditional Chinese medicine. The disclosure describes a material operational and commercial milestone—the \"first commercial deployment of end-to-end blockchain-based medicinal material provenance in the traditional Chinese medicine industry\"—that represents a significant business development for ATGL's blockchain infrastructure offering. While not a discrete M\u0026A transaction, debt issuance, or earnings event, this partnership announcement constitutes a material operational/strategic business event that would affect a reasonable investor's assessment of ATGL's market position and revenue prospects in the healthcare-blockchain sector.","company_name":"Alpha Technology Group Ltd","ticker":"ATGL","filing_date":"2026-06-16","form":"6-K","submitted_at":null,"items":[{"id":9164,"accession_number":"0001213900-26-069086","item_number":"EX-99.1","item_title":"ea029478301ex99-1.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"This exhibit announces a strategic partnership between Alpha Technology Group and Wai Yuen Tong Medicine Co. Ltd. to deploy a blockchain-based traceability system for traditional Chinese medicine. The disclosure describes a material operational and commercial milestone—the \"first commercial deployment of end-to-end blockchain-based medicinal material provenance in the traditional Chinese medicine industry\"—that represents a significant business development for ATGL's blockchain infrastructure offering. While not a discrete M\u0026A transaction, debt issuance, or earnings event, this partnership announcement constitutes a material operational/strategic business event that would affect a reasonable investor's assessment of ATGL's market position and revenue prospects in the healthcare-blockchain sector.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-22T02:39:04.281295+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":9164,"accession_number":"0001213900-26-069086","item_number":"EX-99.1","item_title":"ea029478301ex99-1.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"This exhibit announces a strategic partnership between Alpha Technology Group and Wai Yuen Tong Medicine Co. Ltd. to deploy a blockchain-based traceability system for traditional Chinese medicine. The disclosure describes a material operational and commercial milestone—the \"first commercial deployment of end-to-end blockchain-based medicinal material provenance in the traditional Chinese medicine industry\"—that represents a significant business development for ATGL's blockchain infrastructure offering. While not a discrete M\u0026A transaction, debt issuance, or earnings event, this partnership announcement constitutes a material operational/strategic business event that would affect a reasonable investor's assessment of ATGL's market position and revenue prospects in the healthcare-blockchain sector.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-22T02:39:04.281295+00:00","company_name":"Alpha Technology Group Ltd","ticker":"ATGL","filing_date":"2026-06-16"}]}